Reyataz Chemical Structure (Image 01)
Reyataz
Product Images NDC 0003-3624
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 0003-3624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Reyataz 150 mg Bottle Label (Reyataz 150mg Label)
This is a description of a medication called "REYATAZ®" in capsule form with a strength of 150 mg. The medication comes in a package of 60 capsules with a specific instruction for pharmacists to not cover up the alert box with a pharmacy label. The text also mentions the importance of finding out which medicines should not be taken with REYATAZ®. There is also information regarding the storage temperature of the medicine, which should be kept between 15°C to 25°C. The text does not provide any more details about the medication, its indications or side effects.*
Reyataz 200 mg Bottle Label (Reyataz 200mg Label)
Reyataz 300 mg Bottle Label (Reyataz 300mg Label)
REYATAZ® (atazanavir) is a capsule medication with a strength of 300 mg. The packaging contains an ALERT label with a warning about medications that should not be taken with this medication. The medication should be kept out of reach of children and stored at room temperature between 15-30°C (59-86°F). The rest of the text is not available due to errors.*
Reyataz 50 mg Packet (Reyataz 50mg Packet)
EYATAZ is an oral powder medication containing atazanavir and is intended for patients who weigh at least 5 kg and are at least 3 months old. Each packet contains 50mg of atazanavir sulfate in 1.5g of powder. This medication contains phenylalanine and should be kept out of the reach of children. Please refer to instructions for use.*
Reyataz Figure A (Reyataz Fig A)
Reyataz Figure B (Reyataz Fig B)
Reyataz Figure C (Reyataz Fig C)
Reyataz Figure D (Reyataz Fig D)
Reyataz Figure E (Reyataz Fig E)
Reyataz Figure F (Reyataz Fig F)
This text suggests that there is a medicine cup with a capacity of 30 milliliters.*
Reyataz Figure G (Reyataz Fig G)
Reyataz Figure H (Reyataz Fig H)
Reyataz Figure I (Reyataz Fig I)
Reyataz Figure J (Reyataz Fig J)
Reyataz Figure K (Reyataz Fig K)
Reyataz Figure L (Reyataz Fig L)
Reyataz Figure M (Reyataz Fig M)
Reyataz Figure N (Reyataz Fig N)
Reyataz Figure O (Reyataz Fig O)
Reyataz Figure P (Reyataz Fig P)
Reyataz Figure Q (Reyataz Fig Q)
Reyataz Figure R (Reyataz Fig R)
Reyataz Figure S (Reyataz Fig S)
Reyataz Figure T (Reyataz Fig T)
Reyataz Figure U (Reyataz Fig U)
Reyataz Fig 1 (Reyataz Figure1)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
